Alnylam Pharmaceuticals, Inc. (ALNY) vs Centene Corp. (CNC)

A side-by-side comparison of Alnylam Pharmaceuticals, Inc. and Centene Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 29, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnALNY vs CNC

growth of $100 · dividends reinvested · last 10y
ALNY +231.3% (+12.7%/yr)CNC +84.8% (+6.3%/yr)ALNY compounded faster over this window
0200400600Start $10020182020202220242026$331$185
ALNY CNC

ALNY vs CNC: by the numbers

  • CNC is the larger company ($31.99B vs $31.73B market cap).
  • ALNY is profitable (16.82% net margin) while CNC runs a net loss (-2.63%).
  • ALNY grew revenue faster over the past five years (47.53% vs 10.35% CAGR).

Metrics side by side

Valuation

MetricALNYCNC
P/E ratio40.05N/A
Forward P/E36.4313.48
P/S ratio6.820.17
P/B ratio24.211.43
EV / EBITDA30.68N/A
FCF yield1.66%27.86%

Profitability

MetricALNYCNC
Gross margin79.72%16.13%
Operating margin20.81%-2.82%
Net margin16.82%-2.63%
ROE59.67%-22.60%
ROIC24.71%-12.90%

Growth (annualized)

MetricALNYCNC
Revenue CAGR (5Y)47.53%10.35%
FCF CAGR (5Y)N/A-1.39%
Total return CAGR (5Y)3.06%0.24%

Frequently asked

Which has grown faster, ALNY or CNC?
Over the past five years, ALNY grew revenue faster — ALNY at a 47.53% CAGR versus CNC at 10.35%.
Is ALNY or CNC more profitable?
ALNY runs the higher net margin — ALNY at 16.82% versus CNC at -2.63%.
How have ALNY and CNC total returns compared?
Over the past 10 years, ALNY delivered 12.84% and CNC delivered 6.70% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 29, 2026.